Laboratories case studies
Learn more about how our strategic, flexible approach enhances safety, efficiency, and data-driven decision-making at every stage of your clinical drug development
Benefit from high-quality, harmonized data from ICON's global lab network, combining clinical informatics, scientific expertise, and cutting-edge technology.
Replication Competent Lentiviruses (RCL) qPCR test
This qualitative qPCR assay validated by ICON is able to detect the VSV-G in a variety of sample matrices, such as whole blood, PBMC (as per FDA guidelines) and FFPE, with high specificity and high sensitivity, meeting the FDA guidelines for RCL molecular testing.
PAC19 VCN ddPCR test
The PAC19 VCN digital droplet (dd)PCR test was validated by ICON to detect and monitor CAR-T (chimeric antigen receptor) cell expansion and persistence in patients receiving anti-CD19 CAR-T therapies.
IVDR Technical File Remediation
ICON was tasked with developing a remediation program encompassing a product portfolio spanning more than seven automated instruments and more than 500 analytes or assays.